KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $4.1 billion.

  • Gilead Sciences' Cash from Operations fell 466.47% to $4.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 billion, marking a year-over-year decrease of 354.22%. This contributed to the annual value of $10.8 billion for FY2024, which is 3524.86% up from last year.
  • Gilead Sciences' Cash from Operations amounted to $4.1 billion in Q3 2025, which was down 466.47% from $827.0 million recorded in Q2 2025.
  • Gilead Sciences' Cash from Operations' 5-year high stood at $4.3 billion during Q3 2024, with a 5-year trough of $827.0 million in Q2 2025.
  • Moreover, its 5-year median value for Cash from Operations was $2.3 billion (2021), whereas its average is $2.4 billion.
  • The largest annual percentage gain for Gilead Sciences' Cash from Operations in the last 5 years was 14552.71% (2024), contrasted with its biggest fall of 4332.76% (2024).
  • Quarter analysis of 5 years shows Gilead Sciences' Cash from Operations stood at $3.2 billion in 2021, then dropped by 19.91% to $2.6 billion in 2022, then decreased by 15.5% to $2.2 billion in 2023, then soared by 37.16% to $3.0 billion in 2024, then skyrocketed by 38.08% to $4.1 billion in 2025.
  • Its Cash from Operations was $4.1 billion in Q3 2025, compared to $827.0 million in Q2 2025 and $1.8 billion in Q1 2025.